Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. BGI Genomics Co., Ltd.
  6. News
  7. Summary
    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BGI Genomics : WHO says it is in talks with China's BGI on test kit after Swedish complaint

08/27/2020 | 08:15am EDT

The World Health Organization said on Thursday it was looking into whether "observed irregularities" in a COVID-19 PCR swab test made by China's BGI Biotechnology (Wuhan) Co, Ltd were linked to how it was used in Sweden.

The WHO said it had asked the maker for a "root cause analysis".

China's BGI Genomics said on Wednesday its diagnostic coronavirus testing kit has "relatively high accuracy", a day after Sweden said about 3,700 people received false positive results due to a fault in the company's product.

The WHO, which has approved the tests for emergency use, said in reply to a Reuters query: "WHO was notified and has activated the complaint procedure for in vitro diagnostics ... to gauge if the observed irregularities were due to the way the test was used.  

  "Specifically, WHO has contacted the manufacturer and requested a root cause analysis... We are continuing the work with BGI to determine if further action is required," it said.

(Reporting by Stephanie Nebehay in Geneva, Roxanne Liu in Beijing and Miyoung Kim in Seoul; writing by Stephanie Nebehay; ; editing by John Stonestreet)


© Reuters 2020
All news about BGI GENOMICS CO., LTD.
04/27BGI GENOMICS  : Ethiopian Launches High - End Covid-19 Testing Lab
AQ
04/26BGI GENOMICS  : Ethiopian Launches High-End COVID-19 Testing Lab at its Hub
AQ
04/26BGI GENOMICS  : Ethiopian Opens Covid-19 Testing Lab
AQ
04/23BGI GENOMICS  : Ethiopian Launches High-End COVID-19 Testing Lab at its Hub
AQ
03/19BGI GENOMICS  : Angola Considers Covid-19 Vaccine Card
AQ
02/22MARKET CHATTER : Chinese Government Invests in Gene Company BGI Genomics
MT
02/21Chinese state fund invests in gene firm BGI
RE
02/10China's coronavirus anxiety super-charges testing business in holiday season
RE
01/30BGI GENOMICS  : China gene firm providing worldwide COVID tests worked with Chin..
RE
2020China's BGI wins 1.5 million coronavirus test kit order from Ethiopia
RE
More news
Financials
Sales 2021 5 542 M 866 M 866 M
Net income 2021 1 643 M 257 M 257 M
Net Debt 2021 - - -
P/E ratio 2021 29,1x
Yield 2021 -
Capitalization 49 009 M 7 659 M 7 662 M
Capi. / Sales 2021 8,84x
Capi. / Sales 2022 9,77x
Nbr of Employees -
Free-Float 99,0%
Chart BGI GENOMICS CO., LTD.
Duration : Period :
BGI Genomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BGI GENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price
Last Close Price 119,56 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers and Directors
NameTitle
Ye Yin General Manager & Director
Yi Qing Chen Chief Financial Officer
Jian Wang Chairman
Song Gang Li Chairman-Supervisory Board
Chang Jian Jiang Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BGI GENOMICS CO., LTD.-7.00%7 659
EXACT SCIENCES CORPORATION-8.00%20 910
GUARDANT HEALTH, INC.-6.16%12 230
INVITAE CORPORATION-25.33%6 239
ADAPTIVE BIOTECHNOLOGIES CORPORATION-34.45%5 438
CAREDX, INC25.95%4 750